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Introduction 
ASH2L (Absent, Small, or Homeotic-Like) encodes the 
protein ASH2L which was named after the Drosophila 
protein Ash2 a known regulator of HOX genes 
(Ikegawa et al., 1999). ASH2L is known to be a 
component of histone H3 lysine 4 (H3K4) 
methyltransferase complexes and H3K4 methylation is 
commonly associated with active gene transcription 
(Ikegawa et al., 1999; Hughes et al., 2004; Dou et al., 
2006; Steward et al., 2006; Cho et al., 2007). Previous 
studies have shown that disruption of ASH2L leads to a
decrease in H3K4 trimethylation, which negatively 
affects gene expression (Dou et al., 2006; Steward et 
al., 2006). Furthermore, disruption of ASH2L or the 
methyltransferases involved in H3K4 methylation can 
lead to oncogenesis mostly through the regulation of 
HOX gene expression (Hughes et al., 2004; Lüscher-
Firzlaff et al., 2008). Interestingly, overexpression of 
ASH2L leads to tumor proliferation and knock-down of 
ASH2L inhibits tumorigenesis, which is the reason why 
ASH2L is thought to be an oncoprotein (Lüscher-
Firzlaff et al., 2008). Understanding the role that 
ASH2L plays in facilitating proper H3K4 methylation 
may provide insight into how disruption of ASH2L can 
lead to abnormal cell proliferation and oncogenesis. 
ASH2L function 
Genetic information and sequence alignments 
identified ASH2L to be homologous to the 
transcriptional activator Drosophila Ash2 (Wang et al., 
2001; Ikegawa et al., 1999). Drosophila Ash2 (Absent, 
small, and homeotic discs) is a member of the Tritho ax 
family, known regulators of developmental homeotic  
genes (LaJeunesse and Shearn, 1995). Mammalian 
ASH2L is known to be important for development 
because ASH2L-null mice exhibit an embryonic lethal 
phenotype (Stoller et al., 2010). Work has established 
ASH2L as a core component of the H3K4 
methyltransferase complexes MLL1-4 and SET1A and 
SET1B. Furthermore, ASH2L containing 
methyltransferase complexes are shown to be important 
for the maintenance of HOX gene expression by 
binding to HOX gene promoters and by adding H3K4 
di- and trimethylation (Fig. 1) (Hughes et al., 2004; Tan 
et al., 2008; Yates et al., 2010). HOX gene expression 
is important for proper development and 
differentiation, and disruption in H3K4 methylation 
leads to defects in HOX gene expression and the 
development of cancer (Tan et al., 2008; Hess, 2006; 
Rampalli et al., 2007; MacConaill et al., 2006; Hughes 
et al., 2004). 
Biochemical data has shown that ASH2L is found in a
methyltransferase core complex composed of ASH2L, 
RBBP5, DPY30, WDR5, and the catalytic SET domain 
containing protein (Fig. 1). This core complex is highly 
conserved and similar to the budding yeast Set1 
complex that consists of Set1 (MLL/SET1), Bre2 
(ASH2L), Swd1 (RBBP5), Swd3 (WDR5), Swd2 
(WDR82), Sdc1 (DPY-30), Spp1 (CFP1/CGBP). 
ASH2L is also known to associate with numerous 
additional factors listed in Table 1. Many of these 
additional factors are thought to associate with ASH2L 
and the H3K4 methyltransferase complexes to target 
the complex to specific sites within the genome (Stoller 
et al., 2010; Cho et al., 2007; Steward et al., 2006; Dou 
et al., 2006; Hughes et al., 2004).  
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Figure 1. ASH2L functions in a histone methyltransferase complex. The role of ASH2L within the MLL histone H3K4 
methyltransferase complex. ASH2L interacts with RBBP5 and DPY-30 increasing the activity of the MLL complex. Histone H3K4 
methylation in mammals peaks at the start sight of open reading frames and is important in active transcription. Knock-down of ASH2L in 
mammalian cells results in a decrease in H3K4 trimethylation and changes in gene expression. 
 
ASH2L interacting protein Function 
MLL1-4/ SET1 A and B Catalytic core; Histone methyltransferase (HMT) 
RBBP5 Component of HMT complex 
DPY-30 Component of HMT complex 
WDR5 Component of HMT complex 
CXXC1 Component of HMT complex 
C16orf53/PA1 Glutamate rich coactivator 
C17orf49 Unknown 
CHD8 Chromatin remodeling factor 
E2F6 Transcription factor 
HCFC1 Host cell factor 
IN080C Unknown 
KDM6A H3K27 demethylase 
KIAA1267 Unknown 
LAS1L Unknown 
MAX Transcription factor 
MCRS1 Transcriptional repressor 
MEN1 Tumor suppressor 
MYST1/MOF Histone acetyltransferase 
NCOA6 Transcriptional co-activator 
PAXIP1/PTIP Transcription factor 
PELP1 Transcription factor 
PHF20 Unknown 
PRP31 Component of spliceosome 
RING2 E3-ligase 
SENP3 Sumo-specific protease 
TAF1, 4, 6, 7, 9 TATA-box binding proteins 
TEX10 Unknown 
TBX1 Transcription factor 
Table 1. 
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ASH2L and Bre2 subunits are important for proper 
histone methylation. Studies done in yeast show that 
deletion of the ASH2L homolog BRE2 leads to a 
complete loss of H3K4 trimethylation and reductions in 
mono- and dimethylation (Dehé et al., 2006; South et 
al., 2010; Roguev et al., 2001). In addition, knock-
down of ASH2L using siRNA globally decreases 
H3K4 trimethylation (Steward et al., 2006; Dou et al.,
2006). These data suggest that ASH2L may act in a 
similar manner to yeast Bre2. From these studies it is 
clear that ASH2L is playing an important role in 
histone methyltransferase complexes in order to 
maintain proper H3K4 methylation and gene 
expression (Patel et al., 2009; Roguev et al., 2001). 
Alternative to ASH2L's function in H3K4 methylation 
ASH2L may also be playing a role in endosomal 
trafficking (Xu et al., 2009). ASH2L, DPY-30 and 
WDR5 were originally implicated in endosomal 
trafficking when siRNA knock-down of these genes 
increased the amount of internalized CD8-CIMPR and 
overexpression increased the amount of cells displaying 
a altered CIMPR distribution (Xu et al., 2009). This 
affect was limited to components of H3K4 
methyltransferases and not to other methyl marks such 
as lysine 9 (Xu et al., 2009). The mechanism in which 
ASH2L and other components of H3K4 
methyltransferase complexes modulate endosomal 
trafficking remains unclear. However, two possible 
mechanisms have been suggested, one is that the H3K4
methyltransferase components are part of an unknown 
complex that regulates trafficking, or that changes in 
H3K4 methylation lead to changes in expression of 
another regulating factor (Xu et al., 2009). 
ASH2L structure 
One way to better understand the function of ASH2L is 
to determine the role of specific domains within 
ASH2L in facilitating H3K4 methylation. There are 
three known isoforms of ASH2L (Wang et al., 2001). 
Isoform 1 is considered the canonical sequence and 
consists of 628 amino acids (Wang et al., 2001). 
Isoform 2 is missing amino acids 1-94 and 541-573 
from isoform 1 (Wang et al., 2001).  
Isoform 3 is missing the amino acids 1-94 from isoform 
1 (Fig. 2) (Wang et al., 2001). There are four identified 
domains within ASH2L which include a N-terminus 
containing a PHD finger and a winged helix motif 
(WH) and the C-terminus containing a SPRY domain 
and a newly identified Sdc1 DPY-30 Interacting 
domain (SDI) (Fig. 2) (Wang et al., 2001; Roguev et 
al., 2001; South et al., 2010; Sarvan et al., 2011; Chen 
et al., 2011). Interestingly, the domains with know 
biological function are the C-terminal SDI domain, 
which is responsible for the interaction with another 
histone methyltransferase component DPY-30 and the 
winged helix motif which binds to DNA (South et al., 
2010; Sarvan et al., 2011; Chen et al., 2011). 
The function of the SDI domain was determined using 
in vitro binding experiments. ASH2L was shown to 
directly interact with DPY-30 without any additional 
MLL or Set1 complex components (South et al., 2010). 
The function of the SDI domain is conserved from 
yeast to humans because the yeast ASH2L homolog 
Bre2 was also shown to interact with the DPY-30 
homolog Sdc1 (South et al., 2010). There are conserved 
hydrophobic residues in both the SDI domain of 
ASH2L and the Dpy-30 domain of DPY-30 that are 
important for binding, which suggests that the 
interaction between the SDI domain of ASH2L and the 
DPY-30 domain of DPY-30 is through hydrophobic 
interactions (South et al., 2010). In addition, binding 
affinities between ASH2L and DPY-30, as well as 
ASH2L and RBBP5 have been determined by 
sedimentation velocity analytical ultracentrifugation 
showing dissociation constants of 0.1 µM and 0.75 µM 
respectively (Patel et al., 2009). Interestingly, in yeast 
the ASH2L homolog Bre2 must interact with Sdc1 
through the SDI domain to interact with the yeast Set1 
histone methyltransferase complex (South et al., 2010). 
In contrast, in vitro experiments have shown ASH2L 
does not require DPY-30 to interact with MLL 
complex. To better understand how ASH2L interacts 
with MLL, in vivo studies must be done to determine if 
DPY-30 is required for ASH2L interaction. However, it 
is quite possible that the yeast and human complexes 
assemble differently. 
 
Figure 2. ASH2L has three known isoforms. Schematic model of the three known isoforms of ASH2L and the amino acid sequence 
changes compared to the canonical isoform 1 (aa 1-628). The positions of known domains within ASH2L are displayed. PHD finger (aa 
95-161), WH motif (aa 162-273), SPRY domain (aa 360-583), and SDI domain (aa 602-628). Isoform 2 and 3 are numbered according to 
isoform 1. 
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The N-terminal winged helix (WH) motif was recently 
discovered when the crystal structure of the N-terminus 
of ASH2L was solved (Sarvan et al., 2011; Chen et al., 
2011). Using in vitro DNA binding analyses as well as 
chromatin immunoprecipitation, it was determined that 
ASH2L can bind DNA at the HS2 promoter region and 
the β-globin locus as well as non-specific DNA 
sequence (Sarvan et al., 2011; Chen et al., 2011). The 
DNA binding activity of ASH2L promotes H3K4 
methylation and gene expression at the β-globin locus 
by 50% when overexpressed in a cell line where 
ASH2L is knocked-down by siRNA (Sarvan et al., 
2011). In addition, chromatin immunoprecipitation 
followed by a tiling array (ChIP-chip) analysis shows 
that disruption of the winged helix motif causes mis-
localization of ASH2L (Chen et al., 2011). It was al o 
shown that the DNA binding activity of the N-terminus 
of ASH2L increases when the C-terminal SPRY and 
SDI domains are present (Chen et al., 2011). 
Altogether, these data suggests that multiple domains in 
ASH2L may contribute to its ability to bind chromatin. 
However, more work will be needed to clearly establish 
the function of each domain. 
The largest of the three identified domains within 
ASH2L is the SPRY domain, which is also conserved 
from yeast to humans. SPRY domains were originally 
named after the SPIa kinase and the RYanodine 
receptor proteins in which it was first identified 
(Rhodes et al., 2005). Multiple crystal structures have 
been solved for proteins that contain an SPRY domain. 
Crystal structures of SPRY domain containing proteins 
show primarily a β-sandwich structure with extending 
loops (Woo et al., 2006b; Kuang et al., 2009; 
Filippakopoulos et al., 2010; Simonet et al., 2007). The 
SPRY domain is thought to be a specific protein-
protein interaction domain with specific partners, but 
instead of recognizing a particular motif or interaction 
domain the SPRY domain binds to interaction partners 
using non-conserved binding loops (Filippakopoulos et 
al., 2010; Woo et al., 2006b; Woo et al., 2006a). SPRY 
domain-containing proteins are involved in a wide 
array of functions including RNA metabolism, calcium 
release, and developmental processes (Woo et al., 
2006b; Kuang et al., 2009; Filippakopoulos et al., 2010; 
Simonet et al., 2007; Woo et al., 2006a). Recent work 
has shown that the C-terminus of ASH2L that contains 
the SPRY domain and the SDI domain are able to 
interact with the other MLL complex member RBBP5 
in vitro (Avdic et al., 2011). This interaction is most 
likely through the SPRY domain and not the SDI 
domain, though further work would need to be done to 
better map this interaction. 
ASH2L also contains a putative Plant Homeo Domain 
(PHD) finger in its N-terminus (Wang et al., 2001). 
PHD fingers are a family of zinc finger domains that 
are known to bind to both modified and unmodified 
histone tails (Bienz, 2006; Mellor, 2006). The struc ure 
of PHD fingers shows that conserved cysteine 
and histidine residues bind to Zn2+ ions (Champagne et 
al., 2008; van Ingen et al., 2008; Champagne and 
Kutateladze, 2009). PHD fingers generally form a 
globular fold, consisting of a two-stranded beta-sheet 
and an alpha-helix. Loop regions of PHD fingers tend 
to vary giving rise to specificity of the domain. Some 
PHD fingers are considered to be readers of epigenetic 
marks by binding to specific modifications or sites on 
histones to stabilize or localize an interaction (Mellor, 
2006). Primarily, PHD fingers have been shown to 
interact with trimethylated histone residues such as 
trimethylated histone H3 lysine 4 and lysine 9 (Mellor, 
2006). There is no known function attributed to the
PHD finger in ASH2L, though in conjunction with the 
winged helix motif it may be necessary for DNA 
binding. However, the PHD finger may also be needed 
in binding to MLL, other MLL/SET1 components, or 
recognizing a specific histone modification or for 
binding to a histone tail. Additional studies are needed 
to determine how the PHD finger of ASH2L and the 
SPRY domain may help the MLL and Set1 
methyltransferase complexes interact and catalyze 
H3K4 methylation. 
Conclusion 
Currently, relatively little is known about the 
contribution of ASH2L to facilitate and or regulate the 
degree of methylation along the eukaryotic genome, but 
disruption of ASH2L and H3K4 methylation both 
appear to play a key role in oncogenesis (Lüscher-
Firzlaff et al., 2008; Hess, 2006). Interestingly, recent 
work has suggested that ASH2L in combination with 
WDR5 and RBBP5 exhibits H3K4 methyltransferase 
activity (Cao et al., 2010; Patel et al., 2009; Patel e  al., 
2011). In addition, this catalytic activity is not 
dependent on the SET domain containing proteins such
as MLL1 (Patel et al., 2009; Cao et al., 2010; Patel et 
al., 2011). One report shows the catalytic activity of the 
ASH2L, WDR5, RBBP5, DPY-30 complex in an i
vitro histone methyltransferase assay is observed but 
only after eight hours of incubation (Patel et al.,2009; 
Patel et al., 2011). In contrast, more methyltransferase 
activity and much shorter incubation times are required 
when these components are incubated with the MLL1 
SET domain containing methyltransferase (Patel et a., 
2009; Patel et al., 2011). This indicates the sub-
complex has poor catalytic activity when the main 
catalytic SET domain-containing subunit is not present 
in the reaction. However, Cao et al. shows that only 
ASH2L/RBBP5 heterodimer is needed for weak H3K4 
methyltransferase activity (Cao et al., 2010). Because 
ASH2L, WDR5, RBBP5, and  
DPY-30 complex does not contain a known 
methyltransferase domain, more work needs to be don
to determine if a new class of methyltransferase has 
been identified and whether or not this 
methyltransferase activity is biologically relevant. 
ASH2L is found to be over abundant in many cancer 
cell lines and knock-down of ASH2L by siRNA can 
prevent tumorigenesis (Lüscher-Firzlaff et al., 2008). 
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ASH2L is important for proper H3K4 methylation but 
how ASH2L contributes to the distribution and degre 
of methylation and its role in gene expression remains 
unclear. To better understand the role of ASH2L in 
methylation and gene expression several questions need
to be addressed. What is the mechanism of interaction 
that contributes to ASH2L's interaction with histone 
methyltransferase complexes? What is ASH2L's role in 
regulating the degree of methylation along genes and 
what genes are affected by changes in ASH2L? 
Additional structural studies will help address the 
mechanism of how ASH2L interacts with other 
methyltransferase complex members and microarray 
experiments will be needed to determine the genes that 
are affected by changes in ASH2L expression levels. 
Addressing these questions could provide valuable 
information for the development specific inhibitors for 
the treatment of various cancers. 
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